DUBLIN, IRELAND--(Marketwired- Feb 27, 2014) - Research and Markets (http://www.researchandmarkets.com/research/93trzd/molecular) has announced the addition of the "Molecular Diagnostics Markets" report to their offering.

The technologies that constitute molecular diagnostics - like first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors, and molecular labels - are influencing the discovery of therapeutic molecules, the screening and diagnosis of patients, and the optimization of drug therapy. In the past few years, this rapidly evolving field has seen several fascinating developments.

This report describes the specific market segment of the in vitro diagnostics market known as molecular diagnostics and includes all of the generally accepted clinical analytical activities in use today. It examines the prevalent clinical-measurement devices, as well as their reagents and supplies as utilized in hospitals, clinics, large reference laboratories and doctor's offices. Diagnostic tests marketed primarily as over-the-counter are generally not included in this report, although there is inevitably some overlap.

Main Objectives of Report

1) Identifying viable technology drivers through a comprehensive look at platform technologies for molecular diagnostics, including probe-based nucleic acid assays, microarrays and sequencing;

2) Obtaining a complete understanding of the chief molecular diagnostics tests--i.e., predictive, screening, prognostic, monitoring, pharmacogenomic and theranostic--from their basic principles to their applications;

3) Discovering feasible market opportunities by identifying high-growth applications in different clinical diagnostic areas and by focusing on expanding markets, such as communicable diseases, cardiology and oncology;

4) Focusing on global industry development through an in-depth analysis of the major world markets for molecular diagnostics, including growth forecasts.

Key Topics Covered:

1. Overview

2. Introduction to Molecular Diagnostics and PCR Technology

3. Business Landscape for the Molecular Diagnostics Market Sectors

4. Overview of Clinical Molecular Diagnostic Platforms on the Market

5. Molecular Diagnostic Testing and Infectious Diseases

6. Cancer Detection Using Molecular Diagnostics

7. Genetics Testing in Molecular Diagnostics

8. Molecular Diagnostics Uses in Industrial Testing and Food Diagnostics

9. Bioterrorism and Molecular Diagnostics

10. Regulatory Requirements

11. Reimbursement Issues and Billing Landscape for Molecular Diagnostics Testing

12. Company Profiles

Companies Mentioned:

Abbott Laboratories

AdvanDx

Agendia

Arcxis Biotechnologies

Agilent Technologies

Ambry Genetics

Atlas Genetics

AutoGenomics, Inc

Beckman Coulter

Becton, Dickinson and Company

Biodesix

Biohelix Corporation

bioMérieux

Bio-Rad Laboratories

Cancer Genetics, Inc

Celera (acquired by Quest Diagnostics)

Cepheid

Clarient, Inc (GE Healthcare)

CombiMatrix Corporation

Cytocell Technologies Ltd

DiagnoCure, Inc

Enzo Biochem

Epigenomics

Exact Sciences Corporation

Exagen Diagnostics, Inc

Exiqon

Genera Biosystems

GenMark Diagnostics, Inc

Genomic Health

Great Basin Corporation

Hologic

Illumina

IntegenX

InterGenetics, Inc

LabCorp

Life Technologies Corporation

Luminex

Myriad Genetics, Inc

Nanosphere

Nanostring

Natera

NetBio

Neogenomics

Nuvera Biosciences

Orion Genomics

PerkinElmer Genetics

Progenika

QIAGEN NV

Roche Diagnostics

Rosetta Genomics Ltd

Seegene

Sequenom, Inc

Siemens Healthcare Diagnostics (Siemens)

Spartan Bioscience

Thorne Diagnostics

Transgenomic

TrimGen

Trovagene, Inc

Veredus Laboratories

Veridex

For more information visithttp://www.researchandmarkets.com/research/93trzd/molecular.

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets

Laura Wood, Senior Manager

[email protected]

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Sector: Diagnostics